Cargando…

Progress in medicinal chemistry. 5 /

PROGRESS IN MEDICINAL CHEMISTRY 5.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ellis, G. P. (Gwynn Pennant), West, G. B. (Geoffrey Buckle), 1916-1990
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Butterworths, 1967.
Colección:Progress in medicinal chemistry ; 5
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover; Progress in Medicinal Chemistry, Volume 5; Copyright Page; CONTENTS; Preface; CHAPTER 1. POLYPEPTIDE ANTIBIOTICS OF MEDICINAL INTEREST; 1. Introduction; 2. Classification of peptides; 3. Techniques of peptide chemistry; 4. Polypeptide antibiotics produced by B. brevis; 5. Peptide antibiotics pioduced by B. subtilis and B. licheniformis; 6. Polypeptide antibiotics produced by other strains of bacilli; 7. Polypeptide antibiotics produced by streptomyces; 8. Polypeptide antibiotics produced by fungi; 9. Polypeptide antibiotics isolated from different sources
  • 10. Biosynthesis of polypeptide antibiotics11. Mechanism of action of polypeptide antibiotics; CHAPTER 2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; 1. Introduction; 2. The nature and mechanism of inflammation; 3. Tests for anti-inflammatory activity; 4. Anti-inflammatory compounds; 5. Mode of action; 6. Uncoupling of oxidative phosphorylation; 7. Inhibition of hyaluronidase; 8. Stimulation of the adrenal cortex; 9. Chelation; 10. Hyperglycaemia; 11. Effects on immunological processes; CHAPTER 3. THE PHARMACOLOGY OF HEPARIN AND HEPARINOIDS; 1. Introduction
  • 2. Complexing properties of heparin, heparinoids and mucopolysaccharides3. Biological reactions of heparin and heparinoids; 4. Anticoagulant activity; 5. Haemorrhage and thrombosis; 6. Chemical structure and biological activity; 7. Absorption, distribution and metabolism; 8. Toxicity; 9. Endogenous heparin and heparinoids; CHAPTER 4. THE HISTIDINE DECARBOXYLASES; 1. Introduction; 2. The measurement of histidine decarboxylase activity; 3. The substrate specificity of histidine decarboxylases; 4. The distribution of histidine decarboxylases
  • 5. The mechanism of action of histidine decarboxylases6. Inhibition of histidine decarboxylation in vitro; 7. Inhibition of histidine decarboxylation in vivo; 8. Factors which modify the histidine decarboxylase activity of tissues; 9. The physiological function of histidine decarboxylases; 10. Concluding remarks; CHAPTER 5. PSYCHOT'ROPIC DRUGS AND NEUROHUMORAL SUBSTANCES IN THE CENTRAL NERVOUS SYSTEM; 1. Introduction; 2. The physiological background; 3. Humoral factors in the brain; 4. Classification and properties of the psychotropic drugs; 5. Psychotropic drugs and neurohumoral processes
  • 6. ConclusionsCHAPTER 6. THE NITROFURANS; 1. Introduction to historical development; 2. Chemical and physical properties of nitrofuran compounds; 3. Synthesis of nitrofurans; 4. Toxicology, pharmacology and tolerancv; 5. Assays of nitrofurans; 6. Metabolism of nitrofurans; 7. Antibacterial properties in vitro; 8. Antibacterial properties in vivo; Addendum; Index